Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Director / PDMR Dealing

1 Oct 2024 11:00

RNS Number : 4443G
Argentex Group PLC
01 October 2024
 

01 October 2024

 

Argentex Group PLC

(the "Company")

Director / PDMR Dealing

 

Argentex Group PLC (AIM: AGFX) announces that Guy Rudolph, Chief Financial Officer, on 30 September 2024 purchased 60,021 ordinary shares of £0.0001 each ("Ordinary Shares") in the Company at a price of 33 pence per Ordinary Share.

Following this transaction, Guy Rudolph's total beneficial interest in the Company is 60,021 Ordinary Shares representing approximately 0.05% of the Company's issued share capital.

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Chief Executive Officer

investorrelations@argentex.com

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell

020 7496 3000

 

Teneo

James Macey White / Victoria Boxall

020 7353 4200

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Guy Rudolph

2

Reason for the notification

a)

 

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name 

 

Argentex Group plc

b)

 

LEI 

2549007V7B928Q178194

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of £0.0001 each

Identification code

GB00BJLPH056

b)

 

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Transaction

Price(s)

Volume(s)

Purchase of Ordinary Shares

£0.33p

60,021

d)

 

Aggregated information

N/A - Single transaction

- Aggregated volume

- Price

 

e)

 

Date of the transaction

30 September 2024

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAUWRSBURRRA
Date   Source Headline
23rd Apr 202510:30 amRNSStatement regarding Argentex Group plc
23rd Apr 20259:48 amRNSForm 8.3 - Argentex Group plc
23rd Apr 20257:00 amRNSHolding(s) in Company
23rd Apr 20257:00 amRNSResponse to Media Speculation & Financial Position
22nd Apr 20257:40 amRNSSuspension - Argentex Group Plc
22nd Apr 20257:15 amRNSFinancial Position & Suspension of trading
15th Apr 202510:30 amRNSPublication of Annual Report and Notice of AGM
11th Apr 20254:35 pmRNSDirector/PDMR Shareholding
7th Apr 202510:21 amRNSDirector/PDMR Shareholding
4th Apr 20259:31 amRNS-RNotice of Investor Presentation
3rd Apr 20253:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:33 pmRNSResults of GM, Grant of Awards, PDMR Notifications
2nd Apr 202512:55 pmRNSAppointment of Non-Executive Director
2nd Apr 20257:00 amRNSFinal Results
19th Mar 20257:00 amRNSNotice of Full Year Results
17th Mar 20253:00 pmRNSShareholder Circular & Notice of General Meeting
21st Jan 20257:00 amRNSTrading Update
4th Dec 202412:00 pmRNSDirector/PDMR Shareholding
9th Oct 20244:00 pmRNSCancellation of Long-Term Incentive Plan
3rd Oct 20243:00 pmRNSDirector / PDMR Dealing
1st Oct 202411:00 amRNSDirector / PDMR Dealing
18th Sep 20247:01 amRNSAppointment of Non-Executive Director
18th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
14th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
9th Jul 20247:00 amRNSHalf year trading update
19th Jun 20245:34 pmRNSResult of AGM
6th Jun 20247:00 amRNSInvestor Presentation of FY 2023 Results
4th Jun 20247:00 amRNSAGFX secures Australian Financial Services License
17th May 20243:30 pmRNSHolding(s) in Company
13th May 20246:20 pmRNSDirector/PDMR Dealings
13th May 20241:45 pmRNSPublication of Annual Report and Notice of AGM
9th May 20246:00 pmRNSResult of Placing and Retail Offer
9th May 202410:40 amRNSDirector / PDMR Dealing
3rd May 20247:00 amRNSRetail Offer
2nd May 20245:55 pmRNSResults of Placing
2nd May 20247:01 amRNSProposed Fundraise
2nd May 20247:00 amRNSFull Year Results For the Year Ended 31/12/2023
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.